Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| Revenues | 25,299.0 | 23,668.0 | 22,317.0 | 23,968.0 | 23,400.0 | 22,835.0 | 20,837.0 | 17,100.0 |
| Revenue growth | 6.9% | 6.1% | -6.9% | 2.4% | 2.5% | 9.6% | 21.9% | -55.9% |
| Cost of goods sold | 16,956.0 | 15,609.0 | 14,906.0 | 16,275.0 | 15,733.0 | 15,305.0 | 15,183.0 | 12,569.0 |
| Gross profit | 8,343.0 | 8,059.0 | 7,411.0 | 7,693.0 | 7,667.0 | 7,530.0 | 5,654.0 | 4,531.0 |
| Gross margin | 33.0% | 34.1% | 33.2% | 32.1% | 32.8% | 33.0% | 27.1% | 26.5% |
| Selling, general and administrative | 5,945.0 | 5,258.0 | 5,665.0 | 6,244.0 | 5,642.0 | 5,723.0 | 4,190.0 | 3,191.0 |
| EBITA | 2,846.0 | 3,273.0 | 2,026.0 | 1,546.0 | 2,151.0 | 1,957.0 | 1,441.0 | 1,206.0 |
| EBITA margin | 11.2% | 13.8% | 9.1% | 6.5% | 9.2% | 8.6% | 6.9% | 7.1% |
| Amortization of intangibles | 427.0 | 435.0 | 386.0 | 377.0 | 376.0 | 481.0 | 116.0 | 74.0 |
| EBIT | 2,419.0 | 2,838.0 | 1,640.0 | 1,169.0 | 1,775.0 | 1,476.0 | 1,325.0 | 1,132.0 |
| EBIT margin | 9.6% | 12.0% | 7.3% | 4.9% | 7.6% | 6.5% | 6.4% | 6.6% |
| Pre-tax income | 1,710.0 | 2,614.0 | 903.0 | 1,056.0 | 1,546.0 | 1,151.0 | 1,061.0 | 931.0 |
| Income taxes | -13.0 | 868.0 | 108.0 | -233.0 | 197.0 | 322.0 | 197.0 | 71.0 |
| Tax rate | | 33.2% | 12.0% | | 12.7% | 28.0% | 18.6% | 7.6% |
| Earnings from continuing ops | 1,723.0 | 1,746.0 | 795.0 | 1,289.0 | 1,349.0 | 829.0 | 1,728.0 | 860.0 |
| Earnings from discontinued ops | | 124.0 | | 4,598.0 | 1,034.0 | 990.0 | -1,516.0 | 819.0 |
| Net income | 1,723.0 | 1,870.0 | 795.0 | 5,887.0 | 2,383.0 | 1,819.0 | 212.0 | 1,679.0 |
| Net margin | 6.8% | 7.9% | 3.6% | 24.6% | 10.2% | 8.0% | 1.0% | 9.8% |
| |
| Diluted EPS | $2.46 | $2.42 | $1.05 | $1.47 | $1.45 | $0.88 | $2.57 | $1.30 |
| Shares outstanding (diluted) | 699.6 | 721.1 | 753.6 | 874.3 | 931.7 | 944.6 | 672.6 | 661.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|